$110.00
ARA 290 is a non-erythropoietic peptide that offers neuroprotection, pain relief, anti-inflammation, and tissue repair, especially for neuropathy.
25 in stock
ARA 290 is a non-erythropoietic peptide that offers neuroprotection, pain relief, anti-inflammation, and tissue repair, especially for neuropathy.
The only component in ARA 290 is a non-linear with an 11-amino acid peptide as referred by PHBSP, Cibinetide and Helix surface peptide.
ARA 290 peptide is investigated for the neuropathic pain associated with type 2 diabetes and sarcoidosis, small nerve fibre loss.
Studies focus on the ARA 290 peptide buy for its ability to reduce inflammation and improve survival after myocardial infarction, and reduce organ dysfunction in haemorrhage models.
The research has ARA 290 sale for its potential in diabetic retinopathy and mitigating the neuroinflammation by acting on the CNS.
It selectively binds with IRR, or ARA 290, as it triggers the tissue protective and anti-inflammatory signalling pathways for the production of red blood cells.
It reduces the production of the pro-inflammatory cytokines like TNF, IL-1, and IL-6 in the context of injury and metabolic stress.
In neuropathic pain, the ARA 290 suppresses the spinal microglia and the astrocyte as it reduces the neuroinflammation in the spinal cord.
It promotes the fibre regrowth along with structural damage in diabetic neuropathy in small fibre neuropathy.
The research indicates that ARA 290 will improve neuropathic symptoms like pain, tingling and allodynia as it helps in metabolic control.
The studies have shown that the mouse models in which the cerebral artery has been studied have shown that ARA 290 will reduce the brain infarction and neuronal apoptosis.
Studies focus on its effect on macrophages, decreasing pro-inflammatory cytokine production (e.g., TNF-α, IL-1β, IL-6).
The research has shown protection against organ dysfunction in experimental models along with acute kidney injury.
The research centres can directly order it from the SunGod Lab’s platform. The bulk orders, handling instructions or batch verification reports are also available on request to ensure further seamless integration into laboratory workflows.
https://www.endocrine.org/hormone-foundation
https://pubmed.ncbi.nlm.nih.gov/26774587/
https://pubmed.ncbi.nlm.nih.gov/22183892/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3883966/
PT-141, also known as Bremelanotide, is a synthetic peptide developed as a melanocortin receptor agonist for the treatment of sexual dysfunction in both men and women. Unlike drugs that act on vascular pathways, PT-141 targets the central nervous system to enhance sexual desire and arousal, making it a novel option for individuals with low libido who may not respond to traditional hormone or PDE5-based therapies.
| Quantity | 10mg |
|---|
IGF-1 LR3 from SunGod Labs is a synthetic, long-acting analog of insulin-like growth factor 1 (IGF-1), a naturally occurring growth factor involved in muscle repair, fat metabolism, cell regeneration, and anabolic growth. The LR3 version has been chemically modified for increased potency and a significantly extended half-life. It is commonly used for muscle development, anti-aging, and recovery.
| Quantity | 1mg |
|---|
GLP- 1 It is the first dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist being studied for enhancing glycemic control and inducing significant weight loss. Its dual action makes it more effective than traditional GLP-1 therapies in both metabolic and cardiovascular health domains.
| Quantity | 10mg, 20mg |
|---|
Research-Grade GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone that plays a key role in blood sugar control and appetite regulation. It is released by the gut after eating and helps lower blood glucose levels by stimulating insulin secretion, reducing glucagon release, slowing gastric emptying and promoting fullness.
| Quantity | 10mg, 6mg |
|---|
